NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
13.15
+0.04 (0.31%)
Oct 30, 2026, 4:00 PM EDT - Market closed
NovoCure Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, NovoCure stock has a consensus rating of "Buy" and an average price target of $26.43. The average 1-year stock price forecast is 100.99% higher than the current stock price, while the lowest is $17 (+29.28%) and the highest is $52 (+295.44%).
Price Target: $26.43 (+100.99%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NovoCure stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI | Evercore ISI | Buy Maintains $23 → $20 | Buy | Maintains | $23 → $20 | +52.09% | Oct 30, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $20 → $15 | Hold | Reiterates | $20 → $15 | +14.07% | Oct 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $29 | Buy | Reiterates | $29 | +120.53% | Oct 26, 2026 |
| Wedbush | Wedbush | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +52.09% | Jul 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 | Buy | Reiterates | $52 | +295.44% | Jul 23, 2026 |
Financial Forecast
Revenue This Year
739.38M
from 655.35M
Increased by 12.82%
Revenue Next Year
806.58M
from 739.38M
Increased by 9.09%
EPS This Year
-1.06
from -1.22
EPS Next Year
-0.78
from -1.06
EPS and Forward PE are based on non-GAAP adjusted numbers.